Medicare, Biden

Biden Administration Proposes Covering Obesity Drugs In Medicare And Medicaid
It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive decisions made by the incoming Trump administration.
Medicare moves to expand coverage for weight-loss drugs Wegovy, Zepbound
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and Zepbound.
Biden wants Medicare, Medicaid to cover pricey weight loss drugs such as Wegovy
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese Americans
Millions of obese Americans would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morni
Biden will move to have Medicare, Medicaid cover GLP-1 weight-loss meds
The outgoing Biden administration will propose that pricey GLP-1 obesity medications such as semaglutide (Wegovy), and tirzepatide (Zepbound) be covered by Medicare and Medicaid.
Obese citizens on weight-loss drugs could get Medicare, Medicaid
The Biden administration has proposed a new rule that would allow Medicare and Medicaid to cover popular weight-loss medications like Wegovy and Zepbound
Biden’s plan for Medicare coverage of weight-loss drugs would drive up costs by billions of dollars
Biden to require Medicare and Medicaid to cover weight loss drugs
President Biden plans to roll out a new plan that would require coverage of weight loss drugs for patients of Medicare and Medicaid. The move could potentially help some seven million Americans pay for the expensive drugs,
Weight loss drugs Wegovy and Zepbound strain budgets amid skyrocketing copays
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
World Socialist Web Site16h
Will Medicare and Medicaid coverage for anti-obesity drugs survive RFK Jr.?
that would require Medicare and Medicaid to provide coverage for anti-obesity medications beginning in 2026. Without ...
Renal & Urology News21h
Biden Seeks Coverage for GLP-1 RA Medications by Medicare, Medicaid
(HealthDay News) — The Biden administration is proposing Medicare and Medicaid coverage for glucagon-like peptide 1 receptor agonist (GLP-1 RA) obesity medications like semaglutide (Wegovy) and ...
phillyvoice.com7d
Obesity drugs would be covered by Medicare and Medicaid under Biden administration proposal
An estimated 7.4 million people would gain access to weight-loss drugs like Ozempic and Zepbound, which have out-of-pocket ...
The Hill7d
Biden proposes Medicare, Medicaid coverage of obesity drugs
The Biden administration proposed a new rule Tuesday that would allow anti-obesity drugs like Wegovy and Zepbound to be ...